Clinical Trial Update: S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epratuzumab with cytarabine and clofarabine in relapsed or refractory acute lymphoblastic leukemia has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clolar (Clofarabine)
• Epratuzumab (epratuzumab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-01-03